Neil Mehta
Appearances
- DateMay 8, 2023SOCIETY: AASLD
Presenter
- DateMay 8, 2023BACKGROUND AND AIMS: Screening tools are needed for early detection of NAFLD-fibrosis. We aimed to identify risk factors for NAFLD-fibrosis in the multiethnic population of the U.S. and thus accelerate development of equitable screening tools…
Presenters
UT Southwestern Medical CenterSpeakers
- DateMay 8, 2023BACKGROUND: The LI-RADS (Liver Reporting and Data Systems) was created to standardize reporting of CT/MR imaging for liver masses in cirrhosis patients at risk of hepatocellular carcinoma (HCC)…
Presenter
Speakers
Stanford Hospital & Clinics - DateMay 18, 2024Background: In the United States, patients with early-stage hepatocellular carcinoma (HCC) listed for liver transplant (LT) receive MELD exception points on the waiting list, as they often do not generate a laboratory MELD score to be competitive for LT…
Presenter
Speakers